HHS Scores Early Win In Boehringer's Medicare Pricing Suit

By Hailey Konnath · July 3, 2024, 11:30 PM EDT

A Connecticut federal judge on Wednesday sided with the U.S. Department of Health and Human Services in Boehringer Ingelheim's challenge to a new Medicare drug price negotiation program, rejecting the pharmaceutical...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Case Information

Case Title

Boehringer Ingelheim Pharmaceuticals, Inc. v. United States Department of Health and Human Services et al

Case Number

3:23-cv-01103

Court

Connecticut

Nature of Suit

Other Statutes: Administrative Procedures Act/Review or Appeal of Agency Decision

Date Filed

August 18, 2023

Recent Articles By Hailey

October 24, 2024
McDonald's Customers File First Suits Over E. Coli Outbreak
October 23, 2024
TriZetto Gets New Damages Trial After Ax Of $200M Awards
October 21, 2024
Google, Meta Want Out Of GoodRx Health Data Sharing Suit
October 18, 2024
HHS Slams Hackensack Meridian's Chevron-Inspired Suit
October 08, 2024
Cedars-Sinai OB-GYN Accused Of Abusing, Harassing Patients
October 08, 2024
Apple Loses Bid For Jury Trial In Masimo Trade Secrets Fight
October 07, 2024
Mednax Gets Final OK For $6M Data Breach Settlement
September 27, 2024
Texas AG Wants Austin's Abortion Travel Fund Shut Down
September 25, 2024
11th Circ. Reverses DOJ Defeat In $400M Kickback Case
September 24, 2024
Full 9th Circ. Vaporizes First-To-File Precedent For FCA Suits